Supplementary financial information

On March 31, 2017, Walgreens Boots Alliance and Prime closed a transaction to form a combined central specialty pharmacy and mail services company AllianceRx Walgreens Prime, as part of a strategic alliance. AllianceRx Walgreens Prime is consolidated by Walgreens Boots Alliance and reported within the Retail Pharmacy USA division in its financial statements. The Company accounted for this acquisition of Prime’s specialty pharmacy and mail services business as a business combination involving non-cash purchase consideration of $720 million consisting of the issuance of an equity interest in AllianceRx Walgreens Prime. There were no significant non-cash transactions in fiscal 2016.

Included in the Consolidated Balance Sheets captions are the following assets and liabilities (in millions):



	2017		2016
Accrued expenses and other liabilities
Accrued salaries and wages	$	1,228	$	1,398
Other	4,245		4,086
	$	5,473	$	5,484

Summary of Quarterly Results (Unaudited)

(in millions, except per share amounts)



	Quarter ended
	November		February		May		August		Fiscal year
Fiscal 2017
Sales	$	28,501	$	29,446	$	30,118	$	30,149	$	118,214
Gross profit	7,116		7,561		7,145		7,340		29,162
Net earnings attributable to Walgreens Boots Alliance, Inc.	1,054		1,060		1,162		802		4,078

Net earnings per common share:
Basic	$	0.97	$	0.98	$	1.08	$	0.76	$	3.80
Diluted	0.97		0.98		1.07		0.76		3.78

Cash dividends declared per common share	$	0.375	$	0.375	$	0.375	$	0.400	$	1.525

Fiscal 2016
Sales	$	29,033	$	30,184	$	29,498	$	28,636	$	117,351
Gross profit	7,419		7,867		7,433		7,155		29,874
Net earnings attributable to Walgreens Boots Alliance, Inc.	1,110		930		1,103		1,030		4,173

Net earnings per common share:
Basic	$	1.02	$	0.86	$	1.02	$	0.95	$	3.85
Diluted	1.01		0.85		1.01		0.95		3.82

Cash dividends declared per common share	$	0.360	$	0.360	$	0.360	$	0.375	$	1.455